These dying patients cannot get experimental drugs


By AGENCY

Autumn Fuernisen was diagnosed four years ago with a terminal brain disorder, juvenile-onset Huntington's disease. Patients with rare diseases often have difficulty qualifying for compassionate use programs for experimental therapies.- Londen Tabor/TNS

AT 15, Autumn Fuernisen is dying.

She was diagnosed at age 11 with a rare degenerative brain disorder that has no known cure or way to slow it down: juvenile-onset Huntington’s disease.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Health

Britain bans sale of disposable vapes
Does pleading insanity mean you can escape legal punishment?
Record-breaking climate change threats to health
How iodine may help keep our breasts healthy
Tuberculosis cases hit record high in 2023
‘Pocket casinos’ are fuelling addiction in both adults and children
Adults can get scoliosis too
‘Zombie’ skin cells that influence ageing in other parts of the body
Get some relief from post-surgical pain with music
Many chronic diseases have a connection to gum disease

Others Also Read